drugset / Trial / NCT01779557

Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate

NCT01779557 ↗

Phase 4 Completed 750 enrolled Chinese PLA General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is to evaluate the effectiveness and safety of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate, investigate the proper dialysis dose for Chinese CAPD patients.

Timeline

Start
2013-02
Primary completion
2019-10
Completion
2021-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baxter Peritoneal Dialysate Unknown 6000 ml Other
Subject Huaren Peritoneal Dialysate Unknown 6000 ml Other